Spectraline Syringe
Payments companies reported to CMS as associated with Spectraline Syringe. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spectraline Syringe, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spectraline Syringe
These are the largest totals companies reported as associated with Spectraline Syringe. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Erin Kreisel | Kansas City, KS | Family | $29.18 |
| Jamie Moore | Clinton, MO | Gerontology (Nurse Practitioner) | $29.18 |
| Rigoberto Ramirez | Kansas City, KS | Clinical Cardiac Electrophysiology | $29.18 |
| Augusto Villa | Jupiter, FL | Cardiovascular Disease | $28.99 |
| Matthew Gillespie | Philadelphia, PA | Pediatric Cardiology | $23.13 |
| James Thompson | Baltimore, MD | Pediatric Cardiology | $17.55 |
Prescribed Spectraline Syringe?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.